Related Experiment Videos
Quantitative relationships between steroid structure and binding to putative progesterone receptors
Journal of Medicinal Chemistry
|September 1, 1977
Summary
Researchers explored the link between the chemical structure of androst-4-en-3-one derivatives and their progesterone receptor binding affinity. A predictive equation was developed, highlighting the significance of molecular shape and hydrophobic interactions.
Area of Science:
- Medicinal Chemistry
- Molecular Pharmacology
- Steroid Chemistry
Background:
- Progesterone receptors (PRs) are crucial in reproductive biology and disease.
- Understanding structure-activity relationships (SAR) of PR ligands is vital for drug development.
- Androst-4-en-3-one derivatives represent a class of compounds with potential PR interactions.
Purpose of the Study:
- To establish quantitative relationships between the chemical structure of androst-4-en-3-one derivatives and their binding affinity to putative progesterone receptors.
- To develop a predictive model for ligand-receptor interactions.
Main Methods:
- Synthesis and characterization of 55 androst-4-en-3-one derivatives.
- In vitro binding assays to determine relative binding affinity to rabbit progesterone receptors.
- Quantitative Structure-Activity Relationship (QSAR) analysis using regression modeling.
Main Results:
- A QSAR equation was derived, correlating binding affinity with structural parameters: pia, pib, surface area in/out of hydrophobic pockets, MK, and conformational changes.
- The equation demonstrated a high predictive capability (r=0.88) for known compounds.
- Surface area parameters, particularly within hydrophobic pockets, significantly influenced binding affinity.
Conclusions:
- The study successfully established a quantitative model for predicting progesterone receptor binding affinity of androst-4-en-3-one derivatives.
- Molecular shape and hydrophobic interactions are key determinants of ligand binding to progesterone receptors.
- The developed model can guide the design of novel PR modulators.